Dehydroepiandrosterone in Nonalcoholic Fatty Liver Disease

QR Code

Dehydroepiandrosterone in Nonalcoholic Fatty Liver Disease

None

Saved in:

Bibliographic Details
Main Authors:	Sumida, Yoshio, Sakai, Kyoko, Ohno, Tomoyuki, Kanemasa, Kazuyuki, Inada, Yutaka, Yoshida, Naohisa, Yasui, Kohichiroh, Itoh, Yoshito, Naito, Yuji, Yoshikawa, Toshikazu
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25413
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Dehydroepiandrosterone on Insulin Sensitivity and Adipocyte Growth in Otsuka Long-Evans Tokushima-Fatty Rats
by: Ishizuka, Tatsuo, et al.
Published: (2011)

Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation
by: Tatiana A. Fedotcheva, et al.
Published: (2025-06-01)

Pure Well-differentiated Adenocarcinoma as a Safe Factor for Lymph Node Metastasis and Recurrence of T1 Colorectal Cancer
by: Ken Inoue, et al.
Published: (2025-07-01)

EFFECTS OF DEHYDROEPIANDROSTERONE SULFATE UPON PHENOTYPE AND IN VITRO FUNCTIONS OF DENDRITIC CELLS
by: N. V. Seledzova, et al.
Published: (2014-07-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

An Additional 30-s Observation of the Right-Sided Colon Using a Novel Endoscopic System with Texture and Color Enhancement Imaging Decreases Polyp Miss Rates: A Multicenter Study
by: Yoshikazu Inagaki, et al.
Published: (2025-07-01)

Liver Biopsy in Transplantation: Nonalcoholic Fatty Liver Disease and the Eosinophils
by: Sugawara, Yasuhiko, et al.
Published: (2011)

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
by: K. A. Andreev, et al.
Published: (2022-01-01)

NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR COMPLICATIONS -WHAT IS THE RELATIONSHIP?
by: V. A. Azizov, et al.
Published: (2013-03-01)

Treatment of Nonalcoholic Fatty Disease in Day Care Municipal Polyclinics
by: A. V. Degtyarev, et al.
Published: (2012-03-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Can Eradication Therapy Reduce the Incidence of Nonalcoholic Fatty Liver Disease?
by: Sun Hyung Kang
Published: (2022-06-01)

Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older
by: S. A. Shalnova, et al.
Published: (2025-01-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
by: E. G. Naydanova
Published: (2015-04-01)

Pathophysiological Mechanisms Linking Obstructive Sleep Apnea to Nonalcoholic Fatty Liver Disease
by: Eptehal Mohammed Dongol, et al.
Published: (2025-06-01)

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy
by: Siwen Shen, et al.
Published: (2025-07-01)

Adherence and barriers to Mediterranean diet in Tunisian patients with nonalcoholic fatty liver disease
by: Ayadi Shema, et al.
Published: (2024-12-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

Impact of Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study
by: Ji Won Kim, et al.
Published: (2022-06-01)

Biochemical and histological changes in two nonalcoholic fatty liver disease models of different severity
by: T. V. Brus, et al.
Published: (2024-07-01)

DOES THE LOW LEVEL OF DEHYDROEPIANDROSTERONE SULFATE (DHEA-S) INDEPENDENTLY INFLUENCE RISK OF DEATH AT AGE 55 YEARS AND OLDER?
by: S. A. Shalnova, et al.
Published: (2017-07-01)

Case Report: Adrenocortical adenoma harboring atypical subclinical Cushing’s syndrome with dehydroepiandrosterone sulfate transferase and cytochrome b5 expression in tumor cells
by: Ichiro Abe, et al.
Published: (2025-07-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Gaurav Bachhav, et al.
Published: (2021-05-01)

Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease
by: Yu Hong, et al.
Published: (2025-07-01)

Disrupted host-microbiota crosstalk promotes nonalcoholic fatty liver disease progression by impaired mitophagy
by: Wenjing Yin, et al.
Published: (2025-07-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

IMMUNOLOGICAL MECHANISMS FOR THE DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH GOUT AND PSEUDOGOUT: A REVIEW OF LITERATURE
by: D. A. Nabieva
Published: (2017-10-01)

Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
by: Onur Baser, et al.
Published: (2024-09-01)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023-06-01)

Нepatoprotective еffects of lithium ascorbate on a model of nonalcoholic fatty liver disease with iron overload
by: T. E. Bogacheva, et al.
Published: (2025-01-01)

Improved Ultrasound Evaluation Method for Diagnosing Nonalcoholic Fatty Pancreatic Disease: Correlation with MRI mDixon-Quant
by: Lin Jiaojiao, Ke Helin, Xu Shaodan, Xiao Yang, Han Lina, Lyu Guorong, Li Shilin
Published: (2025-06-01)

Mineral Water Tib-2 in Treatment of Patients with Nonalcoholic Steatohepatitis
by: N. V. Efimenko, et al.
Published: (2012-09-01)

Nonalcoholic Fatty Liver Disease in Patients with Normal Body Weight: Epidemiology, Current Issues of Screening and Diagnosis, Approaches to Therapy
by: I. G. Nikitin, et al.
Published: (2025-07-01)

The clinical signiﬁcance of adiponectimics in formation of aﬀected target-organs during the metabolic syndrome associated with nonalcoholic fatty liver disease
by: E. A. Saginova, et al.
Published: (2011-03-01)

Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis
by: Cai JW, et al.
Published: (2025-07-01)

PSpa Treatment of Nonalcoholic Fatty Liver Disease in Patients with Metabolic Syndrome with Drinking Mineral Water of Essentuki Type Applications
by: T. E. Fedorova, et al.
Published: (2012-12-01)

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India
by: Sounak Sinha, et al.
Published: (2025-06-01)

A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease
by: Jinping Yin, et al.
Published: (2025-06-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)